Data / Drug companies / Shandong Anxin Pharmaceutical Co., Ltd.
Shandong Anxin Pharmaceutical Co., Ltd.: 11 products in the FDA NDC directory, labeler code 35369
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Shandong Anxin Pharmaceutical Co., Ltd. (labeler code 35369) lists 11 products in the FDA National Drug Code Directory, covering 1 finished drug by generic name. By type: 7 bulk ingredients, 4 prescription drugs. Its main marketing category is bulk ingredients. The newest product started marketing on February 26, 2025.
The request: Watch Shandong Anxin Pharmaceutical Co., Ltd. (FDA labeler code 35369): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 35369
- Products in commercial distribution
- 11
- Packages
- 12
- Finished drugs by generic name
- 1
- Prescription products
- 4
- Over the counter products
- 0
- Flagged as original packager
- 4 of 4 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- December 10, 2014
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 5 | 45.5% |
| Generic drugs (ANDA) | 4 | 36.4% |
| Bulk ingredients for compounding | 2 | 18.2% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 7 | 63.6% |
| Prescription drugs | 4 | 36.4% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Piperacillin and tazobactam | 4 | 13 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 7 | 63.6% |
| Injection, powder, for solution | 3 | 27.3% |
| Injection, powder, lyophilized, for solution | 1 | 9.1% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Penicillin-class Antibacterial | 4 |
| beta Lactamase Inhibitor | 4 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Docetaxel | 35369-0022 | Powder | Bulk ingredients | February 26, 2025 |
| Irinotecan hydrochloride | 35369-0020 | Powder | Bulk ingredients | July 5, 2023 |
| Piperacillin and Tazobactam | 35369-0504 | Injection, powder, lyophilized, for solution | Generic drugs (ANDA) | April 14, 2023 |
| Piperacillin sodium and tazobactam sodium | 35369-0007 | Powder | Bulk ingredients for compounding | November 23, 2019 |
| Amikacin sulfate | 35369-0005 | Powder | Bulk ingredients | April 18, 2019 |
| Hydroxyurea | 35369-0006 | Powder | Bulk ingredients for compounding | April 11, 2019 |
| Piperacillin and Tazobactam | 35369-0503 | Injection, powder, for solution | Generic drugs (ANDA) | August 10, 2018 |
| Piperacillin and Tazobactam | 35369-0502 | Injection, powder, for solution | Generic drugs (ANDA) | August 10, 2018 |
| Piperacillin and Tazobactam | 35369-0501 | Injection, powder, for solution | Generic drugs (ANDA) | August 10, 2018 |
| Capecitabine | 35369-0010 | Powder | Bulk ingredients | December 10, 2014 |
| Tazobactam sodium | 35369-0009 | Powder | Bulk ingredients | December 10, 2014 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.